THIOREDOXIN SYSTEMS AKTIEBOLAG
556492-7860ActiveDeveloping novel antibiotic targeting bacterial redox systems for AMR.
Biomedical Companytxnsystems.com
Oversikt
- 3
- Ansatte
- 125t SEK
- Omsetning
- 1995
- Grunnlagt
Nøkkelbeslutningstakere
Mohamad Takwa
Business Advisor and Board Member
@txnsystems.com+46723XXXXXX
Elias S.J. Arnér
CEO
@txnsystems.com
Annette Alaeus
Advisory Board Member
@txnsystems.com
Patrik Gille-Johnson
Advisory Board Member
@txnsystems.com
+10 flere kontakter i Funnelfeedr
Beskrivelse
Thioredoxin Systems AB is a Swedish biomedical company focused on combating antimicrobial resistance (AMR). They are developing EbsArgent™, an innovative antibiotic regimen specifically designed for complicated urinary tract infections (cUTI). This novel treatment targets the bacterial antioxidant r...